Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart Provides Business Update and Reports Full Year 2025 Financial Results

March 12, 2026 - … net   2,826     3,557     Goodwill   4,508     4,508       Total assets $ 186,079   $ 166,389               Liabilities … related to sale of future royalties   4,060     5,758     Total liabilities   98,281     107,464     Stockholders’ equity   87,798     58,925       Total liabilities and stockholders’ equity $ 186,079   $ …
Event

Vaxart, Inc. Full Year 2025 Business Update and Financial Results Conference Call

Thu, 03/12/2026 - 16:30 - … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast March 12, … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast March 12, …
Event

Vaxart, Inc. Stockholder Fireside Chat

Fri, 03/13/2026 - 16:30 - … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast March 13, 2026 … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast March 13, 2026 …
Event

Oppenheimer 36th Annual Healthcare Life Sciences Conference

Wed, 02/25/2026 - 16:00 - … 36th Annual Healthcare Life Sciences Conference Event Type Conference Presentation Listen to Webcast February 25, … 36th Annual Healthcare Life Sciences Conference Event Type Conference Presentation Listen to Webcast February 25, …
Event

Vaxart to Participate in the Global BioInnovation

Tue, 01/13/2026 - 14:30 - … Vaxart to Participate in the Global BioInnovation Event Type Conference Presentation Listen to Webcast January 13, … Vaxart to Participate in the Global BioInnovation Event Type Conference Presentation Listen to Webcast January 13, …
News

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

November 13, 2025 - …                       4,508                      4,508 Total assets $                208,988   $             166,389 …                       3,514                     5,758 Total liabilities                   182,232                   …                      26,756                     58,925 Total liabilities and stockholders’ equity $                …
Event

Vaxart, Inc. Stockholder Fireside Chat

Tue, 11/18/2025 - 16:30 - … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast November 18, … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast November 18, …
Event

Vaxart, Inc. Third Quarter 2025 Business Update and Financial Results Conference Call

Thu, 11/13/2025 - 16:30 - … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast November 13, … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast November 13, …
News

Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate

News

Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results

August 13, 2025 - … 3,192     3,557     Goodwill         4,508     4,508       Total assets       $ 164,085   $ 166,391                     … related to sale of future royalties   2,907     5,758     Total liabilities         131,207     107,465     Stockholders’ equity       32,878     58,926       Total liabilities and stockholders’ equity $ 164,085   $ …
Scroll to Top